Investor Atlas

2080 Ventures · Investor research

33 Post-IPO investors targeting United States

Compare 33 Post-IPO investors targeting United States. Review the selection, investor types and reported focus with 2080 Ventures.

33matching investors
0individual investors
33organizations

What this selection covers

This guide contains 33 distinct directory identities matching target markets: United States; funding stages & types: Post-IPO. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting United States” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Post-IPO is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (33), Corporate Venture Capital (4), Fund of Funds (1), Private Equity (1).

Common reported sector tags: Healthcare (22), Fintech (18), SaaS (17), Enterprise (14). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for United States, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Post-IPO, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 33 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
Ally Bridge Group
Venture CapitalView profile ↗
Anzu Partners
Venture CapitalView profile ↗
Atlantic Bridge
Venture CapitalView profile ↗
Axon Partners Group
Venture Capital, Fund of Funds, Private EquityView profile ↗
Bain Capital
Venture CapitalView profile ↗
Benchmark
Venture CapitalView profile ↗
BonAngels Venture Partners
Venture CapitalView profile ↗
Flagship Pioneering
Venture CapitalView profile ↗
Fonds de solidarité FTQ
Venture CapitalView profile ↗
Forbion Capital Partners
Venture CapitalView profile ↗
G Squared
Venture CapitalView profile ↗
General Catalyst
Venture CapitalView profile ↗
HealthCap
Venture CapitalView profile ↗
Intel Capital
Venture Capital, Corporate Venture CapitalView profile ↗
Irving Investors
Venture CapitalView profile ↗
IVP
Venture CapitalView profile ↗
Khosla Ventures
Venture CapitalView profile ↗
Kinnevik
Venture CapitalView profile ↗
Maverick Capital
Venture CapitalView profile ↗
New Era Capital Partners
Venture CapitalView profile ↗
Nextech Invest
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
Pontifax
Venture CapitalView profile ↗
Ribbit Capital
Venture CapitalView profile ↗
Sequoia Capital
Venture CapitalView profile ↗
SR One
Venture Capital, Corporate Venture CapitalView profile ↗
TVM Capital Life Science
Venture CapitalView profile ↗
VanEck
Venture CapitalView profile ↗
Venrock
Venture CapitalView profile ↗
Versant Ventures
Venture CapitalView profile ↗
Vistara Growth
Venture CapitalView profile ↗
Wellington Partners
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.